News
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those between 12 and 64 with at least one underlying risk factor as defined by the Centers for Disease Control and Prevention.
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
What to Expect on MSN3d
Should Pregnant Women Still Get the COVID-19 Vaccine?You may be debating whether or not you should get the COVID-19 vaccine during pregnancy, especially since there are conflicting guidelines, messages, and stories about whether or not it's recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback